Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Pharma Execs Don't Know Why Anyone Is Upset by a $94,500 Miracle Cure

The company selling a costly breakthrough to millions of hepatitis C sufferers thinks price is the wrong thing to talk about.

Published
09 June 2015
From
Bloomberg
UNITAID brings innovation to the global response to HIV/AIDS, TB and Malaria

At a meeting in Rio de Janeiro, the Executive Board announced it would as a first step focus investments in three areas: improving antiretroviral therapy for adults in low and middle-income countries; enabling the expanded use, or "scale-up", of first pre-exposure prophylaxis (PrEP) as a means of preventing HIV transmission; and the development of better tools to diagnose hepatitis C virus (HCV), in particular for people who are co-infected with HIV/HCV.

Published
08 June 2015
From
UNITAID
Treatment For Welsh Hepatitis C Patients With Advanced Liver Disease

All Wales Medicines Strategy Group has recommended Daklinza® (daclatasvir) to be used, in combination with other medicinal products, as an option to treat eligible NHS patients with chronic hepatitis C and advanced liver disease.

Published
08 June 2015
From
Swansea Sound
Hepatitis B and C co-infection linked to worse liver fibrosis than hepatitis B alone

People with both hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infection may experience more rapid and severe liver disease progression than those with hepatitis B

Published
08 June 2015
By
Liz Highleyman
Hepatitis C treatment could halve HCV transmission among gay men in UK over 10 years

Access to more effective hepatitis C treatment could halve new infections among men who have sex with men in the United Kingdom over the next decade, according

Published
05 June 2015
By
Keith Alcorn
Appalachia gripped by hepatitis C epidemic, bracing for HIV

Patton Couch, 25, is one of thousands of young Appalachian drug users recently diagnosed with hepatitis C. Yet public health officials warn that it could get much worse. Two hundred miles north, Scott County, Indiana, is grappling with one of the worst American HIV outbreaks among injection drug users in decades. Kentucky, with the nation's highest rate of acute hepatitis C, might be just a few dirty needles away from a similar catastrophe. "One person could be Typhoid Mary of HIV," said Dr. Jennifer Havens, an epidemiologist at the University of Kentucky's Center on Drug and Alcohol Research, who has studied Perry County drug users for years as the hepatitis rate spiraled through small-town drug circles there. An explosion of hepatitis C, transmitted through injection drug use and unprotected sex, can foreshadow a wave of HIV cases.

Published
04 June 2015
From
CNS
Reinfection after hepatitis C cure: prevention may require long-term support for people who have injected drugs

Reinfection rates after hepatitis C cure among people who inject drugs, as well as past drug users, are relatively low, according to findings from studies from Norway

Published
04 June 2015
By
Keith Alcorn
Sofosbuvir plus daclatasvir for 12 weeks cures HCV for most people with HIV/HCV co-infection

Nearly all trial participants with HIV and hepatitis C virus (HCV) co-infection, who were treated for 12 weeks with an interferon- and ribavirin-free regimen of sofosbuvir

Published
03 June 2015
By
Liz Highleyman
Patients Get Extreme to Obtain Hepatitis Drug That's 1% the Cost Outside U.S.

This is how far one Express Scripts Holding Co. executive was willing to go to secure inexpensive versions of Gilead Sciences Inc.’s hepatitis C drug Sovaldi, unavailable to U.S. consumers under federal drug import and patent laws. His plan: Dock a cruise ship flying an Indian flag off the coast of Miami. Stock the ship with versions of Sovaldi sold in India for $83,000 less than the U.S. retail price for 12 weeks of treatment. Ferry U.S. patients to the boat and send them home with the potentially life-saving medicines at a huge discount.

Published
02 June 2015
From
Bloomberg
Almost Three Quarters of HIV/HCV Group May Have DDA-ARV Interactions

Among 125 HIV/HCV-coinfected people taking antiretrovirals in a Denver group, 70% could have moderate or severe interactions with one of four common direct-acting antiviral (DAA) regimens for HCV.

Published
02 June 2015
From
NATAP

Filter by country